Organization · Venture Capital
Swanlaab USA Ventures
Swanlaab USA Ventures is a venture capital firm based in New Castle, Delaware, focusing on Series A and B investments in B2B technology and software companies. The firm emphasizes impactful technologies, particularly in artificial intelligence and healthcare.
Overview
What Swanlaab USA Ventures does
What Swanlaab USA Ventures is
Swanlaab USA Ventures is a venture capital firm based in New Castle, Delaware, focusing on Series A and B investments in B2B technology and software companies. The firm emphasizes impactful technologies, particularly in artificial intelligence and healthcare.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2021
- Approximate age
- About 5 years
- Structured capabilities
- Funder
- Last reviewed
- April 22, 2026
Official channels
Find Swanlaab USA Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Swanlaab USA Ventures as a funder
Investment thesis
Swanlaab USA Ventures focuses on intermediate-stage (Series A-B) disruptive B2B and deep-tech investments, particularly in AI and healthcare, with an emphasis on impactful technologies.
Focus narrative
The fund primarily invests in B2B technology and software companies that are at the Series A and B financing stages. Swanlaab USA Ventures emphasizes artificial intelligence and technology-forward companies in sectors such as healthcare, information technology, and the Internet. The investment strategy is designed to achieve Alpha through diversification and a clear focus on impactful technologies.
Value beyond capital
Swanlaab USA Ventures adds value to its portfolio companies by leveraging its extensive network and experience in the venture capital space, particularly through its connections in the Israel-US corridor. The fund typically aims to lead rounds and build syndication for follow-on investments, providing strategic guidance and support to help companies scale effectively.
Focus and fit
- Stages
- Series A · Series B
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 5
- Recorded notable exits
- XtremIO, Soluto, Oplus, and Actimize
Portfolio context
Notable investments from Swanlaab's sister funds include XtremIO (acquired by EMC for $435 million), Soluto (acquired by Asurion for over $100 million), Oplus (acquired by Intel for over $100 million), and Actimize (acquired by NICE Systems for $281 million). The USA fund has disclosed investments in companies such as Can-Fite and DSP Group.
Common questions
What to know about Swanlaab USA Ventures
Upseed classifies Swanlaab USA Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 22, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.